CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Sandoz, Inc. vs. Genentech, Inc.

Explore the PTAB proceeding IPR2017-02036 filed by Sandoz, Inc. on 2017-08-31. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Proceeding Overview

Proceeding Number

IPR2017-02036

Filing Date

2017-08-31

Accorded Filing Date

2017-08-31

Institution Decision Date

2018-04-04

Last Modified Date

2022-10-10

Proceeding Type

IPR

Termination Date

โ€”

Trial Status

Institution Denied

Parties & Counsel

Petitioner

Patent Owner / Respondent

Patent Information

1 Patent Involved
Respondent Application Number 12052606
Respondent Patent Number 7976838
Legal Expiration Date
2025-06-30 Expired (Term Ended)
Injunction Viability (35 U.S.C. ยง 283) Statutorily Barred
Respondent Inventor MARK C. BENYUNES
Respondent Tech Center TC 1600 - Biotechnology & Organic Chemistry

Tribunal & APJ Panel Intelligence

Board Intelligence

Tribunal

Patent Trial and Appeal Board (USPTO)

Technology Center

TC 1600 - Biotechnology & Organic Chemistry

Decisions Rendered

0 Total

Proceeding Status

Institution Denied

Administrative Patent Judges (APJ Panel)

Panel assignment tracked upon institution decision entry

Address and Attorney/Agent Information

41 Registered Practitioners

Power of Attorney & Correspondence

Firm / Entity Name SIDLEY AUSTIN LLP
Customer Number 33694
Address 2021 McKinney Avenue, Suite 2000, Dallas, TX, 75201, UNITED STATES

Attorney / Agent Information

Reg # Name Phone
35910 Sean Johnston +1 650-225-3562
39209 Robert Hall +1 650-225-8203
40378 Wendy Lee +1 650-225-1994
46585 Brian Buckwalter +1 650-225-8018
46631 Cara Coburn +1 650-225-1000
47668 Susan Hubl +1 650-763-7326
48314 Grant Kalinowski +1 650-467-2607
48492 Gregory Zinkl +1 650-922-2382

Global Patent Family Cross-Litigation Radar

CasLoc 360ยฐ Radar 4 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

๐Ÿ‡บ๐Ÿ‡ธ
U.S. District Courts Counterparts in force
๐Ÿ›๏ธ
USPTO PTAB Trials 5 proceedings
๐Ÿ‡ช๐Ÿ‡บ
Unified Patent Court (UPC) Counterparts in force
๐Ÿ‡ฉ๐Ÿ‡ช
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (4): ๐Ÿ‡บ๐Ÿ‡ธ US
Parallel Proceedings Across Jurisdictions (5 found):
PTAB: 5
USPTO PTAB Trial 2018-05-04
IPR2018-01019

Celltrion, Inc. et al. v. Genentech, Inc.

Asserted Patent
Status: Terminated
USPTO PTAB Trial 2017-08-29
IPR2017-01923

Pfizer, Inc. v. Genentech, Inc.

Asserted Patent
Status: Final Written Decision
USPTO PTAB Trial 2016-08-24
IPR2016-01667

Celltrion Inc. v. Genentech, Inc.

Asserted Patent
Status: Institution Denied
USPTO PTAB Trial 2015-08-14
IPR2015-01733

Celltrion, Inc. v. Genentech, Inc.

Asserted Patent
Status: Institution Denied
USPTO PTAB Trial 2014-12-15
IPR2015-00417

Boehringer Ingelheim Pharmaceuticals, Inc. v. Genentech, Inc.

Asserted Patent
Status: Terminated-Settled
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Proceeding Documents

79
13

Decision - Denying Institution of Inter Partes Review - 37 CFR 42.108 Paper

2018-04-04 FILING PARTY: BOARD
12

Petitioner's Authorized Reply to Patent Owner's Preliminary Response Paper

2018-02-02 FILING PARTY: PETITIONER
11

Order - re Petitioner's Request for Authorization to File Reply to Patent Owner Preliminary Response Paper

2018-01-25 FILING PARTY: BOARD
2006

"Arthritis Foundation Statement on Rituximab for Rheumatoid Arthritis" submitted, on May 10, 2012, by Genentech, Inc. to the European Patent Office as an exhibit (D61) to an appeal in the Opposition Proceedings in EP 1613350 Exhibits

2018-01-05 FILING PARTY: PATENT OWN
2003

J.K. Jenkins & K.J. Hardy, Biological Modifier Therapy for the Treatment of Rheumatoid Arthritis, 323(4) Am. J. Med. Sci. 197-205 (2002) Exhibits

2018-01-05 FILING PARTY: PATENT OWN

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc